Nicholas Ward, MD retweeted
On Saturday, 9/6 at the #SH25 Workshop in Cincinnati, learn about EBV+ lymphoproliferative disorders from Ashish Kumar, MD, PhD from Cincinnati Children’s Hospital. Register here! society-for-hematopathology.… #SH25 #hemepath #lymsm
Nicholas Ward, MD retweeted
Join us at the 2025 SH-EA4HP Workshop, Sept. 4-6 in Cincinatti. On 9/5, Dr. Jeffrey Klco MD, PhD, will speak about “Advances in the Molecular Characterization of Pediatric AML.” For more information: society-for-hematopathology.… #SH25 #leusm #hemepath
Nicholas Ward, MD retweeted
At the #SH25 Workshop, learn about transient abnormal myelopoiesis and myeloid leukemia of Down Syndrome from renowned expert, Johann (Hans) Hitzler, MD. Join us in Cincinnati Sept. 4-6! Register at society-for-hematopathology.… #hemepath #leusm
Nicholas Ward, MD retweeted
Nicholas Ward, MD retweeted
🎉Congratulations to all the newly-matched future #HemePath fellows! To view your result, log in to the NRMP website: nrmp.org/fellowship-applican….
Share where you matched with #HemePathMatch26 #FellowMatch !
For more information check out SH’s webpage: society-for-hematopathology.…
Nicholas Ward, MD retweeted
Are you a pathology trainee interested in a #hemepath fellowship? Big news: most hemepath fellowship programs will be moving to a match process for positions that begin in 2026! For more information: society-for-hematopathology.…
Nicholas Ward, MD retweeted
The WHO Classification of Haematolymphoid Tumours, 5th edition, is now finalized 👏😊 and is available on-line at
secure-web.cisco.com/1Gj0EGC…
It will soon be available as a two volume printed book. #hemepath #lymphoma #WHO – at Baltimore, MD
Nicholas Ward, MD retweeted
➡️ Read the press release 📰 of this exciting milestone here: nyulangone.org/news/fda-clea…
75 y/o history of MDS
-Flow cytometry CD45(dim+), CD34(-), HLA-DR(-), CD42b(-) and CD61(-)
-Complex cytogenetics; NGS x2 p53 mutations
-Core biopsy and aspirate smears
Nicholas Ward, MD retweeted
ABPath announced today that all future Primary and Subspecialty exams will be administered exclusively at commercial testing centers. Read the full announcement at https://nitter.cf/t.co/vAfbtC1ERY #pathology #pathboards
Nicholas Ward, MD retweeted
A tribute to #eosinophils from a comparative and evolutionary perspective (source: Journal of Allergy and Clinical Immunology Volume 147 Issue 3 Pages 1115-1116 (March 2021) DOI: 10.1016/j.jaci.2020.12.002). Wright-Giemsa stain. ×100 objective.
Nicholas Ward, MD retweeted
NEW: The NYC marathon—the world's biggest—will return on November 7.
33,000 runners will be permitted. Registration opens June 8.
Nicholas Ward, MD retweeted
Check out these fantastic and short lectures (" Molecular in a Minute") on various molecular #pathology topics. " ALL FREE", and one time enrollment is good for all lectures. @AMPath @AlannaChurch_MD @akkari_yassmine @NateBaileyMD @sabahkadri
amp.org/education/amp-molecu…
Nicholas Ward, MD retweeted
We are getting excited for #EAHPSH2021 and all of our new educational offerings. Will you join us on Sunday?
#hemepath #hematopatholog #lymphoma #BoneMarrow
@SocforHemepath
R/R extra-nodal NK/T-cell lymphoma high response with pembrolizumab (anti-PD1 antibody). Paper NCCN cites uses the SP263 clone (we have 22C3 & SP142), both look positive.. Some evidence IHC may not be best method to detect response (structural rearrangements PDL1 may be better?)
Nicholas Ward, MD retweeted
Happy #flowpostit Monday!
Let's talk about AF (#autofluorescence) 😉:
#flowedu #flowcyto #cytonerds #flowcytometry
Nicholas Ward, MD retweeted
3D pathology.
Using serially cut H&E sections and AI-based automatic annotations of cells and non-cell components, we can map the architecture/compositions of large volumes of human tissues/tumors at single-cell resolutions
More here: biorxiv.org/content/10.1101/…


































